Related Experiment Video
Updated: Jul 13, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older men
Robert Clarke1, Jonathan R Emberson, Sarah Parish
1Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Richard Doll Building, Old Road Campus, Roosevelt Drive, Oxford OX3 7LF, England. robert.clarke@ctsu.ox.ac.uk
Insights
Blood lipid levels, excluding total cholesterol, are linked to ischemic heart disease (IHD) risk in older men. Achieving lipid level differences seen with statin use may reduce IHD risk by one-third.
Area of Science:
- Cardiovascular Medicine
- Gerontology
- Lipidology
Background:
- The role of blood lipids in ischemic heart disease (IHD) risk for older adults remains unclear, leading to infrequent cholesterol-lowering therapy prescription in this demographic.
- Existing guidelines do not routinely recommend cholesterol-lowering treatments for the elderly due to uncertain IHD risk associations.
Purpose of the Study:
- To investigate the association between various blood lipid levels and IHD mortality in an aging male population.
- To clarify the predictive value of specific lipid markers for cardiovascular events in older men.
Main Methods:
- A 7-year follow-up study of 5344 men (mean age 76.9 years) was conducted, assessing plasma levels of total cholesterol, LDL cholesterol, HDL cholesterol, apolipoprotein B, and apolipoprotein A(1).
- The cohort included individuals with and without pre-existing cardiovascular disease (CVD) or statin use.
- Hazard ratios (HRs) for 447 IHD deaths were calculated for a 2-standard deviation difference in lipid levels.
Main Results:
- Total cholesterol levels showed no significant association with IHD mortality overall, but a positive association was found in men without CVD and a non-significant inverse association in men with CVD.
- Low-density lipoprotein cholesterol and apolipoprotein B levels demonstrated similar patterns, with higher risks in men without CVD.
- High-density lipoprotein cholesterol and apolipoprotein A(1) levels were inversely associated with IHD risk in both subgroups.
- Combined lipid ratios (total/HDL cholesterol and apolipoprotein B/A(1)) showed strong associations with IHD risk across all ages.
Conclusions:
- Blood lipid profiles, beyond total cholesterol, are significantly associated with IHD risk in older men.
- Lipid level modifications achievable with statin therapy correlate with a substantial reduction (approximately one-third) in IHD risk, regardless of age.
Background:
The relevance of blood lipid levels as risk factors for ischemic heart disease (IHD) in older people is uncertain; hence, cholesterol-lowering therapy is not routinely prescribed in older populations.
Methods:
We assessed IHD mortality associations with plasma levels of total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, apolipoprotein B, and apolipoprotein A(1) measured in older men. Ischemic heart disease was assessed in a 7-year follow-up of a cohort of 5344 men (mean age, 76.9 years), including 74.3% without cardiovascular disease (CVD) or statin use and 25.6% with CVD or statin use. Hazard ratios (HRs) for 447 deaths from IHD were estimated for a 2-SD difference in usual plasma lipid levels.
Results:
Ischemic heart disease mortality was not significantly associated with total cholesterol levels in all men (HR, 1.05), but a significant positive association in men without CVD and a slight nonsignificant inverse association in men with CVD were observed (HR, 1.47 vs 0.84). The patterns were similar for low-density lipoprotein cholesterol levels (HR, 1.50 vs 0.98) and for apolipoprotein B levels (HR, 1.68 vs 0.93). Ischemic heart disease risks were inversely associated with high-density lipoprotein cholesterol levels and with apolipoprotein A(1) levels in men with and without CVD. Ischemic heart disease risks were strongly associated with total/high-density [corrected] lipoprotein cholesterol levels (HR, 1.57) and apolipoprotein B/apolipoprotien [corrected] A(1) levels (HR, 1.54), and remained strongly related at all ages.
Conclusions:
Blood lipid levels other than total cholesterol levels were associated with IHD in older men. Differences in lipid levels that are achievable by statin use were associated with about a one-third lower risk of IHD, irrespective of age.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis III: Management
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease IV: Preventive Measures
Lipids: Dietary Sources and Requirements
Atherosclerosis I: Introduction
